Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

The Clinical Efficacy of Intravesical Botox Injections When Combined with HoLEP Surgery in Patients with Benign Prostatic Hyperplasia and Overactive Bladder

Next Previous
Trial Profile

The Clinical Efficacy of Intravesical Botox Injections When Combined with HoLEP Surgery in Patients with Benign Prostatic Hyperplasia and Overactive Bladder

Status: Not yet recruiting
Phase of Trial: Phase IV

Latest Information Update: 21 Jan 2025

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Botulinum-Toxin-A (Primary)
  • Indications Benign prostatic hyperplasia; Overactive bladder
  • Focus Therapeutic Use

Most Recent Events

  • 16 Jan 2025 Planned initiation date changed from 30 Nov 2024 to 1 Jun 2025.
  • 05 Jan 2024 Planned End Date changed from 1 Jul 2026 to 1 Jul 2027.
  • 05 Jan 2024 Planned primary completion date changed from 1 Jul 2026 to 1 Jul 2027.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top